BMRN Competitors & Alternatives
Compare Biomarin Pharmaceutical Inc with similar stocks in the same industry
Biotechnology
BMRN
Main Stock$56.50
Tradestie Score
65
Market Cap
$10.53B
P/E Ratio
40.2
Revenue Growth
0.0%
Analyst Upside
+55.5%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$238.59
|
$12.36B | 26.9 | 55 | Compare |
|
EXEL
Exelixis Inc
|
$51.34
|
$11.09B | 17.0 | 60 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$32.21
|
$10.76B | - | 63 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$61.00
|
$10.74B | - | 60 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$75.99
|
$10.49B | - | 64 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$68.63
|
$10.22B | - | 65 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$513.43
|
$10.01B | - | 60 | Compare |
|
TECH
Bio-Techne Corp.
|
$56.26
|
$9.33B | 79.4 | 56 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$79.85
|
$8.88B | 227.7 | 55 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$69.62
|
$8.77B | 24.2 | 61 | Compare |
More BMRN Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry